Bespoke Extracts, INC 10-Q quarterly reports

Bespoke Extracts, Inc. announced a significant increase in sales and gross profit for the nine months ended September 30, 2025, alongside a reduced net loss, but continues to face substantial doubt regarding its ability to continue as a going concern.

Bespoke Extracts, Inc. reported increased sales and a narrower net loss for the quarter and six months ended June 30, 2025, but faces significant liquidity challenges and a going concern warning.

Bespoke Extracts, Inc. reported a reduced net loss of $260,521 for the first quarter of 2025, driven by increased sales and production efficiencies, but continues to face substantial doubt about its ability to continue as a going concern due to a significant working capital deficit and reliance on external financing.

Bespoke Extracts, Inc. saw a rise in sales during the third quarter of 2024, but the company still experienced a net loss and faces ongoing concerns about its ability to continue as a going concern.

Bespoke Extracts, Inc. saw a significant increase in sales during the second quarter of 2024, but continues to operate with a working capital deficit and negative cash flows, raising concerns about its ability to continue as a going concern.

Bespoke Extracts, Inc. saw a significant increase in sales during the first quarter of 2024, but continues to operate with a working capital deficit and negative cash flows, raising concerns about its ability to continue as a going concern.

Bespoke Extracts, Inc. saw a significant increase in sales during the third quarter of 2023, primarily due to its cannabis operations, but continues to face substantial financial challenges and going concern issues.